Advanced Micro Devices (AMD) Pre-earnings Analysis AMD is up more than 100% this year as it becomes the second golden child of the artificial intelligence boom after Nvidia. The company has seen record revenue growth, major AI partnerships, and expansion into data centers in the past 12 months, making it one of the hottest stocks on the market. But as shares hover near record highs, many investors are nervous about whether or not the company can meet earnings expectations. The quarterly earnings report is set for November 4th after market close and expectations are high. Revenue is forecast to grow about 28% from a year ago and earnings per shares by 30-35%. If AMD can meet these expectations, that would...
Hims & Hers Health (HIMS) Pre-earnings Analysis The popular telehealth company Hims & Hers is gearing up to report earnings this week on November 3rd after market close. The stock is up more than 80% year to date, but the past six months have been uneventful as investors assess whether or not the company’s growth is sustainable. Hims started off as a company focused on men’s health, but has expanded into women’s health in recent years, allowing them to sustain revenue growth. The company has also expanded into international markets and introduced several new products to continue boosting growth. The problem we see with their continuous introduction of new products is that it may not be a path to sustainability....
Apple Pre-earnings Analysis Apple just tapped the $4 trillion market cap for the first time in history, making them the second largest company by market cap after Nvidia. That puts pressure on them to perform on earnings, otherwise they’re rising losing investor confidence from these highs and trigger profit taking. The biggest focus on earnings will be iPhone sales. The new iPhone 17 was supposed to spark a big upgrade cycle, with most analysts expecting about a 10% revenue growth from phone sales alone. This is a key metric to watch because it will measure how this model is doing compared to the iPhone 16. Counterpoint Research shows that iPhone sales during the first 10 days after launch in U.S....
Google Pre-earnings Analysis Not long ago, Google was lagging far behind the market, but optimism around their core advertising business, cloud & AI momentum, and regulatory relief has sparked a monster rally, leaving the stock up 42% YTD at the time of this writing. But as earnings approach and as the stock sits at record highs, the question is whether or not they’ll post a strong enough report to maintain these highs, or if their earnings are already priced in. Looking at the numbers, Google is expected to post revenue of $99.94 and earnings per shares of $2.26. The company has a long history of meeting and exceeding expectations, so there’s a good probability they’ll do so this time again....
Merck & Company Pre-earnings Analysis As market valuations get stretched to record highs, investors are searching for “undercover” opportunities to take on. The pharmaceutical space is of those “undercover” opportunities that has lagged far behind the market rally, potentially being a good place for investors with a longer time horizon to park capital. Before getting into the upside, let’s talk about why pharmaceuticals are trading far behind the market:The most prominent reason pharmaceutical stocks aren’t catching rhythm is because of the ongoing regulatory and pricing pressure from the current administration. In the U.S., there’s a strong policy rhetoric around forcing drug price reductions, creating margin risk for investors. And beyond pricing, tariffs on pharmaceutical imports is also a threat. For...
